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Flavonoids such as naringenin, quercetin, and naringin are known to exhibit anticancer
properties. In this study, we examined the effects of these flavonoids on cell viability and
apoptotic pathways of cancer cells, either singly or in combination with the type 1
ribosome inactivating protein, Balsamin. Treatment with flavonoids (naringenin,
quercetin, and naringin) plus Balsamin for 48 h reduced HepG2 and MCF-7 cell
viability, increased the activation of caspase-3 and -8, and induced apoptosis through
up-regulation of pro-apoptotic genes and down-regulation of anti-apoptotic genes. Out of
the three flavonoids tested, the Balsamin-Naringenin and Balsamin-Quercetin
combinations appeared to be most effective compared to the Balsamin-Naringin
combination. Balsamin combined with flavonoids also activated endoplasmic reticulum
(ER)-stress–mediated apoptosis in breast cancer (MCF-7) cells, which was not activated
by Balsamin treatment alone. These experimental results showed that Balsamin
combined with flavonoids can reduce HepG2 and MCF-7 cells viability and induce
apoptosis, which could be considered as a promising therapeutic approach to sensitize
cells to Balsamin treatment, thereby improving its efficacy in breast or liver cancer therapy.
Keywords: bioactives, naringin, naringenin, quercetin, therapeutics, ribosome inactivating proteinsINTRODUCTION
Flavonoids are group of polyphenolic compounds found in fruits, vegetables, herbs, cereals, and
dairy products (Cook and Samman, 1996). Flavonoids as a complementary medicine have attracted
the attention of researchers due to their diverse pharmacological properties, including antioxidant,
antibacterial, antiviral, antitumor, anti-atherosclerosis, antidiabetic, anti-inflammatory,
antithrombogenic, hypolipidemic, and neuroprotective effects (Huang et al., 2016). Such
biological diversity of flavonoids appears to be associated with their ability to regulate a number
of cell signaling cascades, and could play a pivotal role in human health (Williams et al., 2004).
Of all the polyphenols known, naringenin (Nar) and its derivatives are known to possess strong
antioxidant potential along with other biologically beneficial effects (Salehi et al., 2019). Nar is a
flavone, a type of flavonoid that is abundantly found in citrus fruits (Puri et al., 2011). It is derived
from the hydrolysis of the glycone form of flavanones, such as naringin (Figure 1) (Erlund, 2004).
Naringin (Nir) is a flavanone glycoside found in grapes and citrus fruits. It consists of two sugarin.org October 2020 | Volume 11 | Article 5744961
Ajji et al. Flavonoids and Balsamin Combination Induced Apoptosisunits (glucose and rhamnose) attached to its aglycon portion,
Nar, at the 7-carbon atom (Figure 1) (Puri et al., 2012; Alam et al.,
2014). Studies have shown that both Nar and Nir exert a variety of
common pharmacological effects including antioxidant, anti-
inflammatory, anticarcinogenic, and hepatoprotective effects
(Bharti et al., 2014). Quercetin (Qu) is a flavonol, another type
of flavonoid that is abundantly found in edible fruits and
vegetables, and has also gained attention in human health. It
consists of two aromatic rings connected via an oxygen containing
heterocyclic ring (Figure 1) (Gibellini et al., 2011). Qu has
reported health benefits similar to Nar and Nir, and it has also
been used therapeutically in allergic conditions (such as asthma,
hayfever, eczema and hives), arthritis, metabolic syndrome and
mood disorders (Kelly, 2011).
Several studies have demonstrated that these flavonoids exhibit
anticancer properties toward various cancers, including liver,
breast, lung, colon, and bladder cancer (Park and M Pezzuto,
2012; Sharma et al., 2017). Nar inhibited the proliferation of breast
cancer (MCF-7) cells by blocking insulin stimulated glucose uptake
in GLUT4 (insulin responsive glucose transporter) expressing,
insulin responsive MCF-7 cells. Nar blocked glucose uptake by
impairing the activation of phosphoinositide3-kinase (P13K), a key
regulator of insulin induced GLUT4 translocation, and inhibiting
the phosphorylation of p44/p42 mitogen-activated protein kinase
(MAPK), a step essential for the insulin signaling pathway
(Harmon and Patel, 2004). Nir induced apoptosis in breast
cancer cells (MDA-MB-231 and BT549) by increasing the
expression of p21 and decreasing the expression of survivin
(inhibitor of apoptosis protein, IAP) and active b-catenine (Li
et al., 2013). Similarly, Qu supressed the expression of survivinFrontiers in Pharmacology | www.frontiersin.org 2and induced G0/G1 phase cell cycle arrest in breast cancer
(MCF-7) cells (Deng et al., 2013). In the case of liver cancer
(HepG2) cells, Qu induced apoptosis via inhibition of FASN
(fatty acid synthase), a metabolic enzyme that is usually
upregulated during early stages of tumorigenesis (Zhao et al.,
2014). Nar and Nir induced apoptosis in HepG2 cells via
mitochondrial mediated activation of caspase-9 and caspase-8
mediated proteolysis of Bid (Arul and Subramanian, 2013;
Banjerdpongchai et al., 2016). This evidence suggests that the
anti-cancer effects of these flavonoids involved various
mechanisms, a desirable trait in cancer therapeutics.
Balsamin (Bal), a type I ribosome inactivating protein (RIP)
from Momordica balsamina, exhibits potent anti-HIV activity
(Puri et al., 2012). It blocks the replication of HIV by inhibiting
the translation step, occurring prior to viral budding and
release (Kaur et al., 2013). Our recent studies have shown
that Bal exhibits DNase-like activity, and broad spectrum
antimicrobial and antioxidant activity (Ajji et al., 2016).
Further, in subsequent studies on the anti-proliferative
effects of Bal on liver (HepG2 and H4IIE) and breast cancer
(MCF-7 and BT549) cells, we showed that Bal induced
apoptosis in liver cancer cells via increasing the expression of
pro-apoptotic markers involved in mitochondrial mediated
(caspase-3, Bax, Bid, Bad, and p53), death receptor mediated
(caspase-3 and -8) and endoplasmic reticulum (ER)-stress–
mediated (GRP78 and CHOP) apoptotic pathways, with no
effect observed in the expression of anti-apoptotic genes (Bcl-2
and Bcl-XL). However, in breast cancer cells, Bal increased the
expression of pro-apoptotic markers and also simultaneously
decreased the expression of anti-apoptotic genes, triggeringA B
FIGURE 1 | Structure of naringin and its hydrolysed product naringenin (A), and quercetin (B).October 2020 | Volume 11 | Article 574496
Ajji et al. Flavonoids and Balsamin Combination Induced Apoptosismitochondrial mediated and death receptor mediated
apoptosis. Interestingly, Bal did not activate the ER-stress–
mediated pathway in breast cancer cells, suggesting diverse
mechanisms of apoptosis induction in different cancer cells
(Ajji et al., 2017).
Bal and flavonoids (Nar, Nir, and Qu) appear to exert
antitumor effects and induce apoptosis through similar
mechanisms in liver (HepG2) and breast (MCF-7) cancer cells,
therefore, we hypothesized that Bal-flavonoid (Nar, Nir, and Qu)
combinations might have additive apoptotic effects on these cells.
Thus, in this study, we examined the effect of co-treatment of Bal
and three flavonoids, namely Nar, Nir, and Qu, on HepG2 and
MCF-7 cells.MATERIALS AND METHODS
Chemicals, Reagents, and Kits
Nar (purity ≥ 95%), Nir (purity ≥ 95%), and Qu (purity ≥ 95%),
trypsin, in vitro toxicology assay kit, Caspase-3 assay kit and
Caspase-8 assay kit were procured from Sigma-Aldrich (USA).
RPMI and DMEM media, and FBS were purchased from Life
Technologies Corporation (California, USA). Total RNA
isolation kit was purchased from Qiagen (Hilden, Germany).
CM Sepharose and Superdex 75 for Balsamin purification were
procured from GE Healthcare (Buckinghamshire, UK). Reagents
used for electrophoresis were purchased from Bio Rad
Laboratories (California, USA). All other reagents were
purchased from Sigma-Aldrich (USA) and were of
analytical grade.
Purification of Balsamin
Balsamin was purified from Momordica balsamina seeds based
on our earlier published method (Kaur et al., 2012). The seeds
were powdered and homogenized in 50 ml of 150 mMNaCl. The
slurry obtained was centrifuged at 12,000 g for 20 min at 4°C.
Following centrifugation, the proteins were precipitated from the
supernatant with the addition of ammonium sulphate. The
precipitate obtained after centrifugation was dissolved in
10 mM phosphate buffer (PB), pH 6.5, and dialysed against the
same buffer. Following equilibration of a CM-Sepharose column
with PB, pH 6.5, the dialysed sample was loaded onto the column
and elution of unbound protein was carried out with PB, pH 6.5.
The bound proteins were eluted with 0.1–0.4 M NaCl in PB, pH
6.5. The peak fractions containing the protein of interest
(analyzed by SDS-PAGE) were pooled, concentrated and
loaded onto a Superdex 75 column equilibrated with PB, pH
6.5. The eluted fractions with the desired protein were pooled,
concentrated, and further used for this study. The purified Bal
was characterized by SDS-PAGE and protein concentration was
determined by the Bradford method (Kaur et al., 2012).
Cell Lines and Cell Culture
Liver (HepG2) and breast (MCF-7) cancer cells lines were
investigated. These cell lines were procured from the American
Type Culture Collection (Rockville, MD, US). HepG2 and MCF-7Frontiers in Pharmacology | www.frontiersin.org 3cells were maintained in RPMI and DMEM media supplemented
with heat inactivated 10% FBS, respectively, in an environment of
5% CO2 at 37°C. These cells were proliferated in T-25 flasks until
80% confluence and split 1:10 and 1:4, separately, in culture dishes
before experiments were performed.
Treatment Groups
For the cell viability assay, the treatment regimes given in
Figure 2 were used. Based on empirical data, treatments
highlighted in Figure 2 were selected for all other assays.
Cell Viability Assay
HepG2 and MCF-7 cells were seeded in 96 well plates in a
seeding density of ~1 × 104 cells/well for 24 h. After incubation,
the cells were exposed to the treatment regimes given in Figure 2
for 24 h. Cell viability was then analyzed using an in vitro
toxicology assay kit. MTT reagent was added to each well and
the cells were incubated for 4 h. The MTT formazon dye crystals
formed during the experiment were dissolved in MTT
solubilization solution and the absorbance was measured using
a microplate reader (Bio-Rad, USA) at a wavelength of 570 nm.
All experiments were performed three times and results were
expressed as mean ± standard deviation.
Morphology Assay
Hep G2 andMCF-7 cells were seeded in 6-well plates in a seeding
density of (~1 × 105 cells/well for 24 h. After 24 h, the cells were
treated with the treatments highlighted in Figure 2 for 48 h. Cell
morphology was then examined using a light microscope.
Caspase-3/-8 Activity Assay
HepG2 and MCF-7 cells were seeded in 24 well plates in a
seeding density of 6 × 104 cells/well) for 24 h. After 24 h, the cells
were treated with treatments highlighted in Figure 2 for 48 h.
After collecting and lysing the cells; caspase-3 and caspase-8
activity was determined immediately. The activity of caspase-3
and caspase-8 in triplicate was determined using caspase-3 and
caspase-8 colorimetric assay kits according to the manufacturer’s
protocol. Briefly, 5 µl of cell lysate and 1X assay buffer were
added to the 96-well plate followed by caspase-3 substrate
(AcDEVD-pNA) and caspase-8 substrate (AcIETD-pNA) to
each well, respectively. The plates were incubated at 37°C for
2 h. Finally, the absorbance of pNA catalyzed by caspase-3 and
caspase-8, respectively were measured using microplate system
at 405 nm. All experiments were performed three times and
results were expressed as mean ± standard deviation.
RNA Extraction and RT-PCR for Gene
Expression Studies
HepG2 and MCF-7 cells were seeded in 24 well plates in a
seeding density of 6 × 104 cells/well for 24 h. After incubation,
the cells were treated with the treatments highlighted in Figure 2
for 48 h. After treatment, total RNA was extracted using a Total
RNA isolation kit (Qiagen) according to the protocol described
by the manufacturer.
Maxima H minus first strand cDNA synthesis kit was used to
synthesize first strand complementary DNA (cDNA) from eachOctober 2020 | Volume 11 | Article 574496
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followed by 85°C for 5 min and 4°C for 5 min, using the
following primers sets: Bid: 5’- GCT GTA TAG CTG CTT
CCA GTG TA -3’ (forward), 5’- GCT ATC TTC CAG CCT
GTC TTC TC -3’ (reverse); p53: 5’- CTG TCA TCT TCT GTC
CCT TC -3’ (forward), 5’- TGG AAT CAA CCC ACAGCTGCA
-3’ (reverse); Bax: 5’- CTG CAG AGG ATG ATT GCC G -3’
(forward), 5’- TGC CAC TCG GAA AAA GAC CT -3’ (reverse);
Bad: 5’- GCA CAG CAA CGC AGA TGC -3’ (forward), 5’- AAG
TTC CGA TCC CAC CAG G -3’ (reverse); Bcl2: 5’- GTG TGG
AGA GCG TCA ACC G -3’ (forward), 5’- CCT CTG TTT GAT
TTC TCC TGG CT -3’ (reverse); Bcl-XL: 5’- GAT CCC CATFrontiers in Pharmacology | www.frontiersin.org 4GGC AGC AGT AAA GCA AG -3’ (forward), 5’- CCC CAT
CCC GGA AGA GTT CAT TCA CT -3’ (reverse); GRP78: 5’-
GGT GAC CTG GTA CTG CTT GAT G -3’ (forward), 5’- CCT
TGG AAT CAG TTT GGT CAT G -3’ (reverse); CHOP: 5’- TGC
TTC TCT GGC TTG GCT GAC -3’ (forward), 5’- CCA AGG
GAG AAC CAG GAA ACG G -3’ (reverse) (see Table 1).
PCR was carried out in a reaction mixture of 10 µl under
following conditions: 95°C for 7 min, 40 cycles at 95°C for 30 s
and 60°C for 1 min, 60°C for 60 s, 55°C–95°C (hold time: 1 s,
temperature increment after hold: 0.2°C), and 20°C for 10 s. All
experiments were performed three times and results were
expressed as mean ± standard deviation.FIGURE 2 | Treatment regime used for the study (IC50 values for Nar, Nir and Qu are 150 mM, 20 mM and 37 mM respectively).October 2020 | Volume 11 | Article 574496
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Data was analyzed using SPSS Statistics software version 22.0.
Data was presented as the mean ± SD for at least three
independently performed experiments unless otherwise
stated. The non-parametric test, Kruskal-Wallis H test, also
known as one-way ANOVA on ranks, was used to compare
the difference between two or more groups. Mann-Whitney U
test was used to compare the difference between two
groups. Probability values with p < 0.05 were considered to
be statistically significant.RESULTS
Growth Inhibitory Effects of Bal Combined
With Flavonoids on Hepg2 and Mcf-7 Cells
We first determined the effect of co-treatment of Bal (25 µg/ml)
and flavonoids (Nar, Nir, or Qu) on the viability of HepG2 and
MCF-7 cells using an in vitro toxicology assay kit. As shown in
Figures 3A, B, the combination of Bal with low dose (0.5 × IC50
dose) of Nar appeared to inhibit the viability of HepG2 and
MCF-7 cells compared to the cells treated with Bal and Nar
alone. However, when the concentration of Nar (1.0 × IC50 and
2.0 × IC50) was increased in combination with Bal, no significant
difference between the Bal-Nar and Nar treated groups was
observed, suggesting that 0.5 × IC50 of Nar with Bal could be
the most effective dose combination (Figures 3A, B).
Further, the trend appeared to be similar when HepG2 and
MCF-7 were treated with Bal-Qu combinations (Figures 4A, B).
However, when HepG2 and MCF-7 cell were co-treated with low
dose (0.5 × IC50) of Nir and Bal, the cell viability tended to
decrease slightly compared to singly treated groups, however, the
effect was not as prominent as observed with low dose (0.5 ×
IC50) of Nar or Qu with Bal. Further, when the concentration of
Nir (1.0 × IC50 and 2.0 × IC50) was increased in combination
with Bal, no significant difference was observed in the groups
treated with Bal-Nir combinations and Nir alone (Figures 5A,
B). These results suggest that flavonoids (Nar, Nir, and Qu)
could increase the anti-proliferative effects of Bal on HepG2 and
MCF-7 cells, with low dose (0.5 × IC50) of flavonoids (Nar, Nir,
and Qu) found to be the most effective dose in combination with
Bal. Therefore, we selected this flavonoid dose in combination
with Bal for further study.Frontiers in Pharmacology | www.frontiersin.org 5Effect of Bal-Flavonoid Combination
on the Morphology of HepG2
and MCF-7 Cells
We next investigated if flavonoids (Nar, Nir, or Qu) could
increase Bal induced apoptotic effects in HepG2 and MCF7
cells. For this, we examined the morphology of HepG2 and
MCF-7 cells treated with combinations of Bal and Nar, Nir, or
Qu, and compounds alone under bright field microscopy. The
results showed that apoptotic morphological changes, such as
loss in cell connections, cell shrinkage, cell surface detachment,
increased cytoplasmic density and more dead cells appeared to
be more prominent in cells treated with Bal-flavonoid (Nar, Nir,
or Qu) combinations compared to single treatments (Figure 6).
Caspase-3 and -8 Activity of Bal
Combined With Nar, Nir, or Qu in
HepG2 and MCF-7 Cells
We further decided to evaluate whether flavonoids (Nar, Nir, and
Qu) increase caspase-mediated apoptotic effects in Bal treated
HepG2 and MCF-7 cells. As shown in Figure 7A, Bal-Nar
treatment tended to increase and appeared to have an additive
effect on caspase-3 and -8 activity in HepG2 and MCF-7 cells
compared to Bal and Nar alone. Further, the trend appeared to be
similar in HepG2 and MCF-7 cells treated with the Bal-Qu
combination (Figure 7B). However, when HepG2 and MCF-7
cells were treated with the Bal-Nir combination, the caspase-3
and -8 activity tended to increase as compared to Nir and Bal
treatment alone, however, did not appear to have an additive
effect (Figure 7C).
Effect of Bal-Flavonoid Combinations on
the Expression of Various Apoptotic
Genes Involved in the Mitochondrial
Cell Death Pathway
We next studied if these flavonoids could increase Bal-induced
mitochondrial apoptotic effects in HepG2 and MCF-7 cells. The
qRT-PCR results showed that Bal-Nar treatment tended to
increase and appeared to have an additive effect on the
expression of Bax, Bid, Bad, and p53 compared to Bal
treatment alone in HepG2 and MCF-7 cells. However, no
significant difference was observed between the groups (Figure
8A). Further, the trend appeared to be similar in HepG2 and
MCF-7 cells treated with the Bal-Qu combination (Figure 8B),TABLE 1 | Primers used for RT-PCR.
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in HepG2 and MCF-7 cells.
In addition, the Bal-Nir combination appeared to increase the
expression of Bax, Bid, Bad and p53 as compared Bal treatment
alone in HepG2 and MCF-7 cells. However, the effect did not
appear to be pronounced and additive compared to Bal-Nar and
Bal-Qu treatment (Figure 8C), suggesting that the Bal-Nar and
Bal-Qu combinations could be considered more effective than
the Bal-Nir combination.
Further, we also evaluated the expression of anti-apoptotic
genes (Bcl-2 and Bcl-XL) in HepG2 and MCF-7 cells treated with
Bal-flavonoid (Nar, Nir, or Qu) combinations. The qRT-PCR
results showed that Bal-Nar treatment tended to decrease the
expression of Bcl-2 and Bcl-XL compared to Bal and Nar
treatment alone in HepG2 and MCF-7 cells, indicating a
possible effect. However, no significant difference was observed
between the groups (Figure 9A). Likewise, the trend appeared toFrontiers in Pharmacology | www.frontiersin.org 6similar, but less pronounced in HepG2 and MCF-7 cells treated
with Bal-Qu and Bal-Nir combinations (Figures 9B, C).
Effect of Bal-Flavonoid Treatment
on the Expression of Genes Involved
in Endoplasmic Reticulum-Stress–
Mediated Apoptosis
To investigate whether Bal-flavonoid treatment could increase
Bal-induced ER stress in HepG2 cells and activate this pathway
in breast cancer (MCF-7) cells, we evaluated the expression of
CHOP and GRP78 in Bal-flavonoid (Nar, Nir, and Qu) treated
HepG2 and MCF-7 cells.
The qRT-PCR results showed that the expression of GRP78
and CHOP tended to increase in HepG2 cells treated with Bal-
Nar (Figure 10A), Bal-Qu (Figure 10B), and Bal-Nir (Figure
10C) combinations compared to Bal and flavonoids (Nar, Nir,
and Qu) treatment alone, indicating a possible additive effect ofA
B
FIGURE 3 | Effect of Bal and Nar on the viability of HepG2 (A) and MCF-7 (B) cells compared with Bal. All values are mean ± SD. SD, standard deviation; n = 3;
*P < 0.05, Kruskal-Wallis H test.October 2020 | Volume 11 | Article 574496
Ajji et al. Flavonoids and Balsamin Combination Induced Apoptosisco-treatment in HepG2 and MCF-7 cells. In the case of MCF-7
cells, Bal treatment alone did not increase the expression of
GRP78 and CHOP. However, when Bal was combined with the
flavonoids (Nar, Qu, and Nir), the expression tended to increase
with respect to Bal alone, but did not increase significantly with
respect to flavonoid (Nar, Qu, and Nir) treatment alone,
suggesting that the effect was entirely due to the presence of
the flavonoid (Nar, Qu, or Nir) in the Bal-flavonoid
combinations (Figures 10A–C).DISCUSSION
The relationship between diet and cancer has been implicated in
number of epidemiological studies (Ross, 2010). Vegetables,
fruits, and cereals contain flavonoids that have antioxidant,
anti-inflammatory and anticancer properties and Nar, Nir, and
Qu are three such flavonoids that have been explored for theirFrontiers in Pharmacology | www.frontiersin.org 7anti-proliferative effects toward various cancer cells. Nar, a
natural flavone exhibits anti-tumor activity toward various
tumor cell types including hepatoma (HepG2), breast cancer
(MCF-7, HTB26 and HTB132), leukemia (K562), human
epidermoid carcinoma (A431), colorectal cancer (SW1116 and
SW837), and glioma cells (C6) (Harmon and Patel, 2004;
Sabarinathan et al., 2011; Arul and Subramanian, 2013;
Ahamad et al., 2014; Abaza et al., 2015; Li et al., 2015). Nir
exerts antiproliferative effects on cancer cells such as breast
cancer (MDA-MB-231 and BT549), liver cancer (HepG2),
bladder cancer (5637), melanoma (A375), and glioblastoma
(U87MG) (Kim et al., 2008; Guo et al., 2016; Li et al., 2016).
Qu possesses antitumor activity against liver cancer (HepG2),
breast cancer (MCF-7), leukemia (HL-60) and prostate cancer
(DU-145 and PC-3) cells (Nair et al., 2004; Niu et al., 2011; Deng
et al., 2013; Zhao et al., 2014).
Nar caused cell death via cytotoxic, genotoxic and apotosis
effect on various cancer cell lines including HT-29, MCF-7 andA
B
FIGURE 4 | Effect of Bal and Qu on the viability of HepG2 (A) and MCF-7 (B) cells compared with Bal. All values are mean ± SD. SD, standard deviation; n = 3;
*P < 0.05, Kruskal-Wallis H test.October 2020 | Volume 11 | Article 574496
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dose dependent manner. However, the effects were found to be
nominal in case of normal cell line, L-929 as the IC50 value of Nar
for L-929 cell line could not be dertemined since the value was
out of range (Kocyigit et el., 2016). Qu induced cytotoxicity in a
dose dependent manner in leukemic (CEM and K562) and breast
cancer (T47D and EAC) cells through DNA fragmentation, cell
cycle arrest and activating intrinsic pathway of apoptosis.
“However, normal cells dervived from human embryonic
kidney (293T) as well as mouse embryonic fibroblast (MEF-1)
were found to be insensitive to quercetin (Srivastava et al., 2016)”
at similar concentrations able to induce death in carcinogenic
cells (different works have already published this result).
Several studies have reported that flavonoids with antioxidant
properties synergize the effect of chemotherapeutic drugs
(Lewandowska et al., 2014). Qu increased cisplatin-induced
apoptosis in human laryngeal cancer (Hep-2) cells (Kuhar
et al., 2007). 4T1 breast tumor mice treated with Qu and
doxorubicin demonstrated inhibition of tumor growth andFrontiers in Pharmacology | www.frontiersin.org 8reduction of doxorubicin side effects, leading to prolonged
survival of the mice (Du et al., 2010). Qu enhanced the
antitumor effect of trichostatin-A, a novel anticancer drug, in
human lung cancer cells through upregulation of p53 expression
(Chan et al., 2013).
Our previous studies demonstrated that Bal, a type I RIP
isolated from Momordica balsamina, exhibits inhibitory effects
toward HIV-1 replication (Kaur et al., 2013) and breast cancer
cells, highlighting its potential as a therapeutic agent. It has
previously been reported that Bal-induced apoptosis involved
increases in caspase-3 and caspase-8 activity, cell cycle arrest at
G-/S- phase, upregulation of Bax, Bid, and Bad, and
downregulation of BCL-2 and BCL-XL (Ajji et al., 2017).
Since flavonoids (Nar, Nir, and Qu) and Bal exerts anticancer
effects, therefore the present study investigated the apoptotic
effects of Bal in the presence of three flavonoids, namely Nar, Nir,
and Qu, on liver (HepG2) and breast cancer (MCF-7) cells. Co-
treatment with Bal (25 µg/ml) and flavonoids (Nar, Nir, or Qu)
enhanced the anti-proliferative effects of Bal on HepG2 andA
B
FIGURE 5 | Effect of Bal and Nir on the viability of HepG2 (A) and MCF-7 (B) cells compared with Bal. All values are mean ± SD. SD, standard deviation; n = 3;
*P < 0.05, Kruskal-Wallis H test.October 2020 | Volume 11 | Article 574496
Ajji et al. Flavonoids and Balsamin Combination Induced ApoptosisFIGURE 6 | Morphology of HepG2 and MCF-7 cells treated with Bal-Nar, Bal-Qu and Bal-Nir compared with Bal, Nar, Qu and Nir alone.A B
C
FIGURE 7 | Effect of Bal-Nar (A), Bal-Qu (B) and Bal-Nir (C) on caspase-3 and -8 activity compared with Bal in HepG2 and MCF-7 cells. All values are mean ± SD.
SD, standard deviation; n = 3; *P < 0.05, Kruskal-Wallis H test.Frontiers in Pharmacology | www.frontiersin.org October 2020 | Volume 11 | Article 5744969
Ajji et al. Flavonoids and Balsamin Combination Induced ApoptosisMCF-7 cells where low dose (0.5 × IC50) of flavonoids (Nar, Nir,
and Qu) in combination with Bal was found to be an effective
dose as compared to other two doses (1.0 × IC50 and 2.0 × IC50)
of Nar, Nir, or Qu, and henceforth the lowest dose (0.5 × IC50) of
Nar, Nir, and Qu was selected in combination with Bal for
further study. These doses were selected based on the empirical
data; however, further investigations would be required to
evaluate appropriate doses of Bal and flavonoids for alleviating
liver and breast cancer in clinical trialsFrontiers in Pharmacology | www.frontiersin.org 10Flavonoids, such as Nar, Nir, and Qu are known to induce
apoptosis in various cancer cells by regulating the expression of
apoptot ic markers (Arul and Subramanian, 2013 ;
Banjerdpongchai et al., 2016). Apoptosis is a programmed and
often energy dependent process that involves activation of
caspases, a group of cysteine proteases, and a complex cascade
of signals (Elmore, 2007). Flavonoids such as Nar, Nir, and Qu
have been reported to activate caspase dependent apoptosis in
cancer cells (Ramos, 2007). Nar and Nir induced apoptosis inA B
C
FIGURE 8 | Effect of Bal-Nar (A), Bal-Qu (B) and Bal-Nir (C) on the expression of pro-apoptotic genes, Bax, Bid, Bad and p53, compared with Bal in HepG2 and
MCF-7 cells. All values are mean ± SD. SD, standard deviation; n = 3; *P < 0.05, Kruskal-Wallis H test.A B
C
FIGURE 9 | Effect of Bal-Nar (A), Bal-Qu (B) and Bal-Nir (C) on the expression of anti-apoptotic genes, Bcl-2 and Bcl-XL, compared with Bal in HepG2 and MCF-7
cells. All values are mean ± SD. SD, standard deviation; n = 3; *P < 0.05, Kruskal-Wallis H test.October 2020 | Volume 11 | Article 574496
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death pathways (Arul and Subramanian, 2013; Banjerdpongchai
et al., 2016). Qu induced cell death in glioblastoma U373MG cells
through proteolytic activation of caspase-3 and caspase-7, a
decrease in mitochondrial membrane potential and increases
in caspase-3 and caspase-9 activities (Kim et al., 2013). Our
previous studies have demonstrated that Bal also induces
apoptosis by increasing the activity of caspase-3 and -8 in
breast cancer cells (Ajji et al., 2017). In this study, Bal in
combination with flavonoids (Nar, Nir, and Qu) had an
additive effect on caspase-3 and -8 activity in HepG2 and
MCF-7 cells compared to Bal and flavonoids (Nar, Nir, and
Qu) alone. Out of three combinations, Bal-Nar and Bal-Qu
appeared to have a more prominent effect compared to Bal-
Nir combination.
Studies have shown that apoptosis is also regulated by the Bcl-
2 family of pro-apoptotic and anti-apoptotic genes. Flavonoids,
such as Nar, Nir, and Qu, have been reported to trigger apoptosis
via regulating the expression of pro-apoptotic and anti-apoptotic
genes involved in the mitochondrial cell death pathway (Ramos,
2008). Nar isolated from Thymus vulgaris upregulated pro-
apoptotic markers, p18, p19, p21, Bax and Bak, and
downregulated anti-apoptotic markers, Cdk4, Cdk6, Cdk7, and
Bcl-2 in human colorectal and breast cancer cells leading to
apoptosis (Abaza et al., 2015). Qu induced apoptosis in HepG2
hepatoma cells by decreasing the Bcl-XL:Bcl-XS ratio, activating
caspase-3 and -9 and increasing the translocation of Bax to the
mitochondrial membrane, leading to mitochondrial mediated
apoptosis (Granado-Serrano et al., 2006). Our previous studies
demonstrated that Bal induces the mitochondrial cell death
pathway in breast cancer cells by increasing the expression of
pro-apoptotic genes, Bax, Bid, Bad, and p53, and decreasing the
expression of anti-apoptotic genes, Bcl-2 and Bcl-XL (Ajji et al.,
2017). In this study, Bal- flavonoid (Nar, Nir, and Qu) treatmentFrontiers in Pharmacology | www.frontiersin.org 11tended to increase and appeared to have an additive effect on the
expression of Bax, Bid, Bad, and p53 in HepG2 and MCF-7 cells
compared to Bal and flavonoids (Nar, Nir, and Qu) treatment
alone, where Bal-Nar and Bal-Qu appeared to have more
pronounced and additive effect compared to Bal-Nir
combination. Increase in activation of caspase-3 and -8,
upregulation of pro-apoptotic genes (Bax, Bid, Bad, p53) and
downregulation of anti-apoptotic genes (Bcl-2 and Bcl-XL) with
Bal-Nar, Bal-Nir and Bal-Qu treatment compared to Bal and
flavonoid (Nar, Nir, or Qu) treatment alone in HepG2 and MCF-
7 cells, suggested that these flavonoids increase Bal-induced
mitochondrial mediated apoptosis with a possible additive
effect in HepG2 and MCF-7 cells, which could be considered
as a promising strategy to sensitize cells to Bal treatment.
The ER stress response has been reported to initiate apoptosis
in various cancer cells, through three different pathways; (i)
activation of CHOP, also known as DNA damage-inducible gene
153 (GADD153), (ii) activation of ER associated caspases and
(iii) activation of c-Jun N- terminal kinase (JNK)-mediated cell
death (G Johnson et al., 2011). Qu induced ER-stress–mediated
apoptosis by increasing the expression of ATF, GRP78 and
CHOP in prostate cancer PC-3 cells (Liu et al., 2014). It has
been reported that Qu pre-treatment elicits ER-stress to enhance
cisplatin cytotoxicity in ovarian cancer cells, indicating that Qu
has a potential to enhance the efficacy of cisplatin induced
apoptosis in ovarian cancer cells (Yang et al., 2015). Our
studies have shown that Bal does not activate ER-stress–
mediated apoptosis in breast cancer (MCF-7 and BT549) cells
(Ajji et al., 2017). However, co-treatment with Bal and flavonoids
(Nar, Nir, and Qu) tended to increase and appeared to have
additive effect on the expression of GRP78 and CHOP in HepG2
cells compared to Bal and flavonoids (Nar, Nir, and Qu)
treatment alone. However, in case of MCF-7 cells, Bal-
flavonoid (Nar, Qu, or Nir) treatment tended to increase theA B
C
FIGURE 10 | Effect of Bal-Nar (A), Bal-Qu (B) and Bal-Nir (C) on the expression of gene, GRP78 and CHOP, involved in ER-stress mediated apoptosis, compared
with Bal in HepG2 and MCF-7 cells. All values are mean ± SD. SD, standard deviation; n = 3; *P < 0.05, Kruskal-Wallis H test.October 2020 | Volume 11 | Article 574496
Ajji et al. Flavonoids and Balsamin Combination Induced Apoptosisexpression GRP78 and CHOP with respect to Bal alone, but did
not increase significantly with respect to flavonoid (Nar, Qu, and
Nir) treatment alone, indicating that the effect was entirely due to
the presence of the flavonoid in the combined treatment. It is
interesting to note that these flavonoids activate ER-stress–
mediated apoptosis, an additional apoptotic pathway, in breast
cancer MCF-7 cells that is not activated by Bal treatment alone.
A number of studies have reported the bioavailability of
flavonoids such as Nar, Qu, and Nir in rats. The plasma
concentration of Nar and Qu metabolites in rats receiving
single meal containing 0.25% Nar and 0.2% Qu after 24 h was
found to be 128 µM and 51 µM, respectively. The plasma
concentration of Nar and Qu increased till 10-12 h after single
feed and decreased thereafter indicating that these flavonoids are
efficiently absorbed in rats (Manach et al., 1997; Felgines et al.,
2000). Our results suggested that consumption of these
flavonoids (Nar, Qu, and Nir) with Bal at selected doses might
be beneficial to prevent and treat liver and breast cancer, thus
advocating its use as a dietary supplement. It could be a
promising therapeutic strategy to sensitize liver and breast cells
to Bal treatment, thereby improving its effectiveness in cancer
therapy. However, further investigations would be required to
evaluate appropriate doses of Bal and flavonoids for alleviating
liver and breast cancer in clinical trials.CONCLUSIONS
To the best of our knowledge, our study demonstrates for the
first time that Bal in combination with flavonoids (Nar, Nir, and
Qu) enhances apoptotic effects in HepG2 and MCF-7 cells
through activation of caspase-3 and -8 and regulation of pro-
apoptotic and anti-apoptotic genes. These results suggested thatFrontiers in Pharmacology | www.frontiersin.org 12Bal with flavonoids (Nar, Qu, and Nir) could be a promising
therapeutic strategy to reduce proliferation in breast and liver
cancer cells and sensitize cells to Bal treatment. However, the
study warrants further investigation to evaluate the efficacy and
appropriate doses of Bal and flavonoids for alleviating liver and
breast cancer in clinical trials.DATA AVAILABILITY STATEMENT
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